TG Therapeutics, Inc. (TGTX) Posts Q3 Loss of 62c/Share
TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q3 EPS of ($0.62) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
